Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

COR Therapeutics, Inc. to Report / Webcast Second Quarter 2001 Financial Results Tuesday, July 17, 2001.


Business Editors/Health & Medical Writers

SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--July 11, 2001

COR Therapeutics, Inc. (Nasdaq: CORR CORR

Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51.
) announced today that it will provide its second quarter 2001 financial results and outlook on Tuesday, July 17, 2001 at 8:00 a.m. Eastern Daylight Time (EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
).

Two hours later, at 10:00 a.m. EDT, as part of the Company's efforts to ensure full disclosure to all parties, COR will webcast a live conference call via the Company's internet site. The call will be led by Vaughn M. Kailian, President and Chief Executive Officer.

The webcast may be accessed by logging onto either http://www.corr.com or http://www.vcall.com/NASApp/VCall/EventPage?ID=75744 on the internet. Please connect to either website at least 10 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the live webcast. In addition, the webcast will be archived and will be available for five business days.

COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction (·kyōōtˑ mī·ō·karˑ·dē· , deep vein thrombosis A blood clot (thrombos) in a vein deep within the muscle, typically in the thigh or calf. It is caused by disease or the lack of activity such as sitting for hours at a computer screen. , and restenosis.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 11, 2001
Words:219
Previous Article:Aspect Medical to Report Second Quarter 2001 Results On July 18th; Conference Call Scheduled for Same Day.
Next Article:Paradise Group Arranges For Production & Assembly Facilities In China.
Topics:



Related Articles
COR Therapeutics, Inc. to Release / Webcast Third Quarter Financial Results Tuesday, October 17, 2000.
COR Therapeutics, Inc. Announces Increased Sales of INTEGRILIN -eptifibatide- Injection and Third Quarter 2000 Financial Results.
COR Therapeutics, Inc. to Report / Webcast Fourth Quarter 2000 Financial Results Tuesday, January 23, 2001.
COR Therapeutics, Inc. Reports Significant Draw Down of Wholesaler Inventory;.
COR Therapeutics, Inc. to Report / Webcast First Quarter 2001 Financial Results Tuesday, April 17, 2001.
COR Therapeutics, Inc. Reports First Quarter 2001 Financial Results.
COR Therapeutics, Inc. Reports Profitable Second Quarter Driven by 60 Percent Year-Over-Year INTEGRILIN Sales Growth.
COR Therapeutics, Inc. Resets Guidance for Third Quarter and Year-End 2001.
COR Therapeutics, Inc. Reports Profitable Third Quarter.
Convertibles make the difference: Tracy Maitland's convertible securities strategy lessened market risk. (Stock Update).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles